Rare diseases
Investigational molecules
Locations
Study of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma
The NetherlandsStudy on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease
The NetherlandsStudy of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy
The NetherlandsLong-term Safety Study of Etranacogene Dezaparvovec in Adult Men with Hemophilia B
The NetherlandsLong-term Study of Zanubrutinib for Patients with B-cell Blood Cancer
The NetherlandsStudy to Identify Unknown Primary Cancer Using [18F]-AlF-FAPI-74 PET-CT for Patients with Carcinoma of Unknown Primary
The NetherlandsStudy of SAR443579 Infusion for Adults and Children with Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia, HR-MDS, or BPDCN
The NetherlandsStudy on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction
The NetherlandsStudy on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment
The NetherlandsStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
The NetherlandsStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
The NetherlandsStudy of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
